Correlation Between Atreca and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Atreca and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atreca and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atreca Inc and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Atreca and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atreca with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atreca and Zentalis Pharmaceuticals.
Diversification Opportunities for Atreca and Zentalis Pharmaceuticals
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Atreca and Zentalis is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Atreca Inc and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Atreca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atreca Inc are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Atreca i.e., Atreca and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Atreca and Zentalis Pharmaceuticals
If you would invest 104.00 in Atreca Inc on September 14, 2024 and sell it today you would earn a total of 0.00 from holding Atreca Inc or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.59% |
Values | Daily Returns |
Atreca Inc vs. Zentalis Pharmaceuticals Llc
Performance |
Timeline |
Atreca Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Zentalis Pharmaceuticals |
Atreca and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Atreca and Zentalis Pharmaceuticals
The main advantage of trading using opposite Atreca and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atreca position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |